
Biologists, biochemists, bioinformaticians, physicians, lab technicians (bachelors in biotechnology), masters and PhD in biomedical sciences, engineers in biotechnology
MDxHealth (previously OncoMethylome Sciences) is a diagnostics company developing molecular tests for early detection of cancer and personalizing treatment decisions. Our personalized treatment tests analyze the molecular makeup of a patient's tumor, providing genetic information that is useful for selecting treatment, such as the likelihood that the tumor will recur and its predicted response to treatment. MDxHealth boasts a broad product development pipeline for very prevalent cancers, applying the patent-protected, DNA methylation technology invented at J.H.U. (USA). MDxHealth was founded in 2003 and has offices in Europe and in the US.